NSE: BASF · BSE: 500042 · ISIN INE373A01013
BASF India Limited stock analysis
BASF India Limited ranks #2127 in the TickerSutra evidence-ranked universe with a score of 48/100 and 95% data confidence. The latest captured fundamentals show ROCE of 14.5%, quarterly sales growth of 28.9% and quarterly profit growth of 137.6%.Avoid / exit review
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- Low debt/equity of 0.03×
- Institutional ownership is rising
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- CFO/EBITDA is below 0.6×
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹13,100cr | ₹911cr | ₹595cr | 7.0% |
| 2023 | ₹13,645cr | ₹687cr | ₹403cr | 5.0% |
| 2024 | ₹13,767cr | ₹890cr | ₹563cr | 6.0% |
| 2025 | ₹14,811cr | ₹742cr | ₹499cr | 5.0% |
| 2026 | ₹14,985cr | ₹656cr | ₹417cr | 4.4% |
| TTM | ₹16,071cr | ₹939cr | ₹632cr | 6.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
Trading window for dealing in Company''s equity shares will remain closed from Thursday 1st October, 2026 and will reopen on Monday, 9th November, 2026
RoutineBASF India Ltd - 500042 - Board Meeting Intimation for Board Meeting Of BASF India Limited To Be Held On 4Th November, 2026BSE · 25 Sept 2026BASF India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for ....
RoutineUpdatesNSE · 21 Sept 2026BASF India Limited has informed the Exchange regarding 'BASF evaluates MDI investment in India'.
RoutineBASF India Ltd - 500042 - BASF Evaluates MDI Investment In IndiaBSE · 21 Sept 2026BASF evaluates MDI investment in India
MANAGEMENT COMMENTARY
Signals from filed documents
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…